Brokerages expect MKS Instruments, Inc. (NASDAQ:MKSI) to report $530.68 million in sales for the current quarter, Zacks reports. Four analysts have provided estimates for MKS Instruments’ earnings. The lowest sales estimate is $530.00 million and the highest is $532.50 million. MKS Instruments reported sales of $437.15 million during the same quarter last year, which would suggest a positive year over year growth rate of 21.4%. The business is expected to report its next earnings report on Wednesday, April 25th.

On average, analysts expect that MKS Instruments will report full year sales of $530.68 million for the current fiscal year, with estimates ranging from $2.10 billion to $2.14 billion. For the next year, analysts forecast that the firm will post sales of $2.27 billion per share, with estimates ranging from $2.23 billion to $2.30 billion. Zacks Investment Research’s sales averages are an average based on a survey of sell-side research analysts that that provide coverage for MKS Instruments.

MKS Instruments (NASDAQ:MKSI) last released its quarterly earnings data on Wednesday, January 31st. The scientific and technical instruments company reported $1.71 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.63 by $0.08. The company had revenue of $512.00 million during the quarter, compared to analysts’ expectations of $500.22 million. MKS Instruments had a net margin of 17.70% and a return on equity of 22.51%. The firm’s quarterly revenue was up 26.4% on a year-over-year basis. During the same period in the previous year, the company earned $1.05 EPS.

Several equities research analysts have issued reports on MKSI shares. Stifel Nicolaus reissued a “buy” rating and issued a $108.00 price objective (up from $98.00) on shares of MKS Instruments in a research report on Tuesday, October 24th. Deutsche Bank upped their price target on shares of MKS Instruments from $104.00 to $116.00 and gave the stock a “buy” rating in a research report on Thursday, October 26th. Dougherty & Co upped their price target on shares of MKS Instruments from $106.00 to $115.00 and gave the stock a “buy” rating in a research report on Thursday, October 26th. ValuEngine cut shares of MKS Instruments from a “buy” rating to a “hold” rating in a research report on Friday, December 1st. Finally, BidaskClub cut shares of MKS Instruments from a “strong-buy” rating to a “buy” rating in a research report on Saturday, December 2nd. Six research analysts have rated the stock with a buy rating and one has given a strong buy rating to the stock. The company has an average rating of “Buy” and an average price target of $116.60.

Shares of MKS Instruments (NASDAQ:MKSI) opened at $99.90 on Friday. The stock has a market cap of $5,269.29, a PE ratio of 16.22, a price-to-earnings-growth ratio of 0.96 and a beta of 1.04. The company has a debt-to-equity ratio of 0.25, a current ratio of 4.21 and a quick ratio of 3.06. MKS Instruments has a 52-week low of $64.45 and a 52-week high of $110.60.

In related news, VP Brian Charles Quirk sold 2,000 shares of the business’s stock in a transaction that occurred on Monday, February 5th. The shares were sold at an average price of $105.10, for a total transaction of $210,200.00. Following the completion of the transaction, the vice president now owns 11,863 shares in the company, valued at approximately $1,246,801.30. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Elizabeth Mora sold 300 shares of the business’s stock in a transaction that occurred on Friday, December 1st. The stock was sold at an average price of $94.10, for a total transaction of $28,230.00. The disclosure for this sale can be found here. Insiders sold a total of 33,252 shares of company stock valued at $3,289,287 in the last ninety days. Corporate insiders own 1.65% of the company’s stock.

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Ameritas Investment Partners Inc. raised its stake in shares of MKS Instruments by 2.9% during the 2nd quarter. Ameritas Investment Partners Inc. now owns 4,733 shares of the scientific and technical instruments company’s stock worth $319,000 after acquiring an additional 135 shares in the last quarter. Aperio Group LLC raised its stake in shares of MKS Instruments by 2.9% during the 3rd quarter. Aperio Group LLC now owns 17,130 shares of the scientific and technical instruments company’s stock worth $1,618,000 after acquiring an additional 489 shares in the last quarter. FDx Advisors Inc. raised its stake in shares of MKS Instruments by 8.7% during the 4th quarter. FDx Advisors Inc. now owns 7,380 shares of the scientific and technical instruments company’s stock worth $697,000 after acquiring an additional 592 shares in the last quarter. CAPROCK Group Inc. raised its stake in shares of MKS Instruments by 26.8% during the 4th quarter. CAPROCK Group Inc. now owns 2,862 shares of the scientific and technical instruments company’s stock worth $275,000 after acquiring an additional 605 shares in the last quarter. Finally, Sit Investment Associates Inc. raised its stake in shares of MKS Instruments by 1.8% during the 4th quarter. Sit Investment Associates Inc. now owns 39,300 shares of the scientific and technical instruments company’s stock worth $3,714,000 after acquiring an additional 700 shares in the last quarter. Hedge funds and other institutional investors own 95.07% of the company’s stock.

TRADEMARK VIOLATION WARNING: “Brokerages Anticipate MKS Instruments, Inc. (MKSI) Will Announce Quarterly Sales of $530.68 Million” was first posted by TheOlympiaReport and is the property of of TheOlympiaReport. If you are reading this article on another website, it was stolen and reposted in violation of U.S. and international copyright & trademark legislation. The legal version of this article can be accessed at https://theolympiareport.com/2018/02/11/brokerages-anticipate-mks-instruments-inc-mksi-will-announce-quarterly-sales-of-530-68-million.html.

About MKS Instruments

MKS Instruments, Inc is a global provider of instruments, subsystems and process control solutions that measures, controls, powers, delivers, monitors and analyzes critical parameters of advanced manufacturing processes. The Company operates through two segments, including the Vacuum & Analysis segment and the Light & Motion segment.

Get a free copy of the Zacks research report on MKS Instruments (MKSI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for MKS Instruments (NASDAQ:MKSI)

Receive News & Ratings for MKS Instruments Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MKS Instruments and related companies with MarketBeat.com's FREE daily email newsletter.